Big News (PHG, HAS, FST, PPHM, LNKD)

NEW YORK, January 11,2013 (MESHPRESS) –  Beststocksdaily.com, an investment community with a  special focus on updating investors with recent news on the U.S. stock market, issues news alert on the following stocks:-

Koninklijke Philips Electronics NV (ADR) (NYSE HG) shares jumped 3.97% and closed at $27.99 in the last trading session. The company, on Dec. 18, announced that it has signed a 10-year managed services agreement with Sint Maartenskliniek for the supply, installation, maintenance and upgrade of radiology imaging equipment within the hospital. This contract will not involve the direct purchase of equipment. Instead, the Sint Maartenskliniek will have the latest medical imaging systems at its disposal for a fixed monthly cost throughout the duration of the multi-year agreement.

Can PHG Continue To Move Higher? Find Out Here

Hasbro, Inc. (NASDAQ:HAS) shares climbed 3.90% and closed at $37.07. The company announced that it will webcast its fourth quarter 2012 results conference call on Thursday, February 7, 2013 at 5:00 p.m. Eastern Time, following the release of Hasbro’s financial results after market close that same day.

Can HAS Extend Jump? Find Out Here

Forest Oil Corporation (NYSE:FST) shares increased 3.89% to $6.95. The company, last week, has announced it will sell its South Texas assets, excluding the Eagle Ford shale, for $325 million as it seeks to raise cash and bring its balance sheet in line and focus efforts on its profitable oil-producing properties.

Additionally, Standard & Poor’s Ratings Services said, on Jan. 7, that its corporate credit rating on Forest Oil Corp. (Forest; B+/Stable/–) remains unchanged following the company’s announcement that it has entered into a definitive agreement to sell its South Texas properties (excluding Eagle Ford acreage) for after-tax proceeds of $325 million.

Can FST Extend Rally? Find Out Here

Peregrine Pharmaceuticals(NASDAQ PHM) shares jumped 3.88% to $2.14 after Roth Capital upgraded shares of Peregrine from a neutral rating to a buy rating in a research report released on Jan. 9. Roth Capital currently has $2.70 price target on the stock.

Additionally,  the company, on Jan. 7, provided an update from its internal review of discrepancies from its Phase II randomized, double-blind placebo-controlled trial of bavituximab in second-line non-small cell lung cancer (NSCLC) in 121 patients. The review was prompted by the discovery of vial coding discrepancies while preparing for an end of Phase II meeting with the FDA.

Will PPHM Bounce Back? Get Free Trend Analysis Here

Linkedin Corporation (NYSE:LNKD) stock increased 3.85% to $118.04. The company, on Jan. 8, announced the appointment of Hari Krishnan as the company’s Managing Director in Asia-Pacific and Japan. Krishnan will be playing a key role in growing LinkedIn’s presence in the Asia-Pacific region and reinforcing LinkedIn’s commitment to connect professionals in Asia-Pacific and Japan to make them more successful and productive.

Additionally, LNKD‘s stock had its “positive” rating reiterated by equities research analysts at Susquehanna in a research note issued to investors today. They currently have a $145.00 price target on the stock.

Moreover, the company said it reached 200 million members world-wide, underscoring the professional social network’s continued growth even as other newly public Web companies stumble.

Can LNKD Extend Rally? Find Out Here

About Beststocksdaily

Beststocksdaily.com team is engaged in providing valuable and updated news information on U.S. stocks on a regular basis. Beststocksdaily.com instant stock news on Major Gainers, small cap penny stocks and various other stocks, guides investors in making the wise stock market investments decision. To Get Instant updates in the inbox, readers are advised to sign up for free at Beststocksdaily.com.

Disclaimer:

The assembled information disseminated by beststocksdaily.com is for information purposes only, and is neither a solicitation to buy nor an offer to sell securities. beststocksdaily.com does expect that investors will buy and sell securities based on information assembled and presented in beststocksdaily.com. PLEASE always do your own due diligence, and consult your financial advisor.

Contact:

beststocksdaily.com

staff@beststocksdaily.com